BioUtah

?? Denali Therapeutics Expands in Utah! Yesterday, Denali Therapeutics celebrated the grand opening of its state-of-the-art manufacturing facility in Salt Lake City, marking a major milestone in the fight against neurodegenerative diseases. CEO Ryan Watts shared how Denali’s vision—pushing the boundaries of scientific discovery—is much like the Utah pioneers who defied the odds to put down roots, build, and ultimately thrive in the state. The event featured remarks from Governor Spencer Cox, Salt Lake City Mayor Erin Mendenhall, BioUtah President & CEO Kelvyn Cullimore, and Denali leaders Cindy Dunkle (Chief People Officer) and Leah Frautschy (VP of Clinical Operations). “With a team of experienced and passionate scientists and professionals, Denali is not only creating an economic footprint in Utah but is also poised to change the lives of so many patients and their families,” said Kelvyn Cullimore, welcoming Denali to Utah’s growing life sciences ecosystem. Congrats to Denali on this exciting milestone! We’re proud to have them as a BioUtah Elite Bronze member. ?? More: https://ow.ly/yVko50VqPBb #LifeSciences #BioUtah #NeurodegenerativeDisease #DenaliTherapeutics #UtahBusiness

We’re excited to welcome DUCT-AID to BioUtah! Founded in Southern Utah, DUCT-AID is revolutionizing emergency care with the first medical-grade duct tape designed to be applied to open wounds—a game-changer in first aid. Their innovative all-in-one first aid kit, which fits inside a roll of their medical-grade tape, is designed to stabilize emergencies anytime, anywhere. Originally conceived by Dr. Mitchell Melling, the company is now led by Wade Melling and Ryan Logan, continuing its mission to make the world a safer place. ?? Join us in welcoming DUCT-AID to the #BioUtah community! Learn more: duct-aid.com #LifeSciences

BioUtah member Paterna Biosciences has been selected as one of 10 companies to participate in the 2025 Mayo Clinic and ASU MedTech Accelerator! This year’s cohort represents five nations and is the first to include life sciences companies. The accelerator offers an immersive curriculum, equipping emerging companies with expertise in regulations, commercialization, and customer acquisition. ?? Congrats to #Paterna Biosciences on this incredible opportunity! ?? Learn more: https://ow.ly/p2u950VnaAu #BioUtah #LifeSciences

ATL Technology Welcomes Jim Fitzgerald as CEO ATL Technology, a global leader in medical device development and manufacturing, is pleased to announce the appointment of Jim Fitzgerald as its new CEO. Mr. Fitzgerald brings an extensive track record of executive leadership in the medical device contract manufacturing industry, having held CEO and senior executive leadership positions at Flexan, MRP Solutions, ITxM, Vesta, and Cardinal Health. His professional journey in the life sciences sector began at Baxter Health, where he developed a deep understanding of the industry’s evolving landscape. Jim takes over for the late Brad Brown, who was recently honored at the 2025 Entrepreneur & Investor Summit. ?? Learn more: https://ow.ly/seCC50VnAzM

ICYMI -- On the Talk Radioisotopes podcast, we sat down with AtomVie CEO Bruno Paquin to discuss the role of CDMOs in accelerating drug development and enabling new treatments. Watch/listen: https://hubs.ly/Q039Qjcn0

I'm thrilled to share below update from BioUtah's 2025 Entrepreneur & Investor Life Sciences Summit. I was proud to present Freyya's mission on stage, highlighting how our #wearable #biofeedback device can empower millions of women to monitor their #pelvicfloor #health. Our team was honored to be selected from 40 applicants to pitch in the Shark Tank-style competition. Although we didn't take home the win, we made invaluable connections, were inspired by incredible speakers, and met new investors. That’s a home run all round.? Thanks Kelvyn Cullimore and Team for putting on a fantastic event.

Calling all regulatory, legal, and compliance professionals! Earn 4 CLE / RAC credits with BioUtah member Gardner Law at Ski-LE – a complimentary legal and regulatory update for FDA-regulated companies. This one-of-a-kind event combines expert insights, networking, and time on Utah's world-class slopes. ?? Cliff Lodge, Snowbird, UT ??? Friday, April 11, 2025 | 7:00 AM–11:00 AM ??? Breakfast & lunch included ?? Earn 4 CLE / RAC credits (UT & MN approved) Featured Speakers: ? Mark Gardner, MBA, Esq., Managing Partner, Gardner Law ? Mike Pisetsky, Chief Business & Legal Affairs Officer, SI-BONE ? Nathan Downing, Managing Attorney, Gardner Law Topics Include: ? Key legal trends in medtech, biotech, and pharmaceuticals ? Fraud and abuse in healthcare compliance ? Real-world marketing compliance challenges ? FDA priorities for 2025 Ski-LE is designed for legal and compliance professionals looking to stay ahead of regulatory changes while enjoying networking and skiing at Snowbird and Alta. Lodging discounts available. Space is limited – reserve your spot now! ?? Register: https://ow.ly/Zq9v50Vph2p ?? Questions? Contact [email protected] #BioUtah #LifeSciences #HealthcareLaw #RegulatoryCompliance #SkiLE2025

BioUtah member, Phoenix DeVentures, a leading provider of product development and turn-key manufacturing services in the MedTech sector, announced that it will be acquired by INDO-MIM Limited, a global leader in precision component manufacturing. This acquisition will result in Phoenix DeVentures becoming a wholly owned subsidiary of INDO-MIM. In keeping with its rich history and to underscore its next evolutionary step in the MedTech industry, the company will be rebranded as PDV MedTech, Inc. Phoenix Deventures has operations in Lehi, Utah as well as other locations around the western United States. ?? More: https://ow.ly/PlTV50VnA6s

For the past several years, BioUtah has been honored to welcome Monica DiCenso, Head of Global Investment Opportunities at J.P. Morgan Private Bank, as a keynote speaker at our annual Entrepreneur & Investor Summit. At #EISummit2025, she once again delivered an insightful overview of market conditions and forecasts for the year ahead. With economic uncertainty driven by federal spending cuts, tariffs and recession concerns, her perspective couldn’t have come at a better time. ?? Hear the key insights Monica shared at the Summit: https://ow.ly/ipUp50Vn9zu #BioUtah #LifeSciences

?? Congratulations to Karsten Eastman and the team at Sethera Therapeutics on their win at the #EISummit2025 Pitch Competition! Sethera is revolutionizing drug discovery with its enzymatic platform, enabling the creation of peptide-based bioactive compounds that were previously inaccessible. By combining enzymatic chemistry with advanced screening methods, Sethera is opening new doors for therapeutic innovation—an advancement that holds incredible promise for the future of medicine. ?? Learn more about Dr. Eastman's work at setheratx.com